ABBOTT SEEKS RETURN OF IVD PLASMA PRODUCTS SEIZED BY FDA
This article was originally published in The Gray Sheet
Executive Summary
ABBOTT SEEKS RETURN OF IVD PLASMA PRODUCTS SEIZED BY FDA in a claim filed March 9 with the U.S. District Court for the Northern District of Illinois, Eastern Division. Abbott's action follows FDA's Feb. 28 seizure of imported plasma products used in manufacturing in vitro diagnostic products including tests for hepatitis B, cytomegalovirus, and toxoplasmosis.